Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials
Top Cited Papers
Open Access
- 30 May 2013
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 382 (9894), 769-779
- https://doi.org/10.1016/s0140-6736(13)60900-9
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation
- BHF Centre of Research Excellence, Oxford (RE/08/04)
- Medical Research Council
This publication has 28 references indexed in Scilit:
- Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational StudiesPLoS Medicine, 2011
- Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysisBMJ, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Emotion Recollected in Tranquility: Lessons Learned from the COX-2 SagaAnnual Review of Medicine, 2010
- Role of Dose Potency in the Prediction of Risk of Myocardial Infarction Associated With Nonsteroidal Anti-Inflammatory Drugs in the General PopulationJournal of the American College of Cardiology, 2008
- Cardiovascular Risk of Celecoxib in 6 Randomized Placebo-Controlled TrialsCell Metabolism, 2008
- Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trialsBMJ, 2006
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac SurgeryNew England Journal of Medicine, 2005